Using pharmacogenetic analysis in clinical management with clozapine (Nasrine, 2023)

Nasrine N., Stevens C., Tam H.-Y., Sivasanker V.

Progress in Neurology and Psychiatry 2023;27(4): 10-14.

A limited response to clozapine treatment is a familiar clinical scenario in patients with treatment-resistant schizophrenia. Here, the authors present a case where pharmacogenetic analysis was able to guide clinical management, and the discussion is expanded into the role of clinic genomics in personalised medicine.Copyright © 2023 John Wiley & Sons, Ltd.